The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

The UW researchers ran a trial with their mice, dosing them with the JAK-inhibitor tofacitinib following the administration of a brain-damaging drug that puts them on the road to repeated seizures.

The researchers found one of the drugs, DDL-920, developed in the UCLA lab of Varghese John, who coauthored the study, produced significant recovery in movement control in mice. This study has two ...

The UW researchers ran a trial with their mice, dosing them with the JAK-inhibitor tofacitinib following the administration of a brain-damaging drug that puts them on the road to repeated seizures.

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in once-cherished activities.

Neurotech startup Precision Neuroscience on Thursday announced that a core component of its brain implant system has been approved by the U.S. Food and Drug Administration, a major win for the ...

Currently, prospective pain drugs are typically tested in animals — whose responses are often different than a human's — and ...

“The shingles vaccines … seem to be one of those drugs,” said Taquet, who was not involved in the study. In medical research, randomized controlled trials are the gold standard for measuring ...